Skip to main content

Christopher Viehbacher

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher Viehbacher

Christopher Viehbacher is recorded as CEO and Board Member at Biogen Inc. (BIIB). The proxy statement of Biogen Inc. reports total compensation of $23,646,004 for Christopher Viehbacher in fiscal 2025, including a base salary of $1,727,885. Disclosed compensation is on record for 4 fiscal years. Christopher Viehbacher has spoken on 6 earnings calls across 1 company, most recently for Biogen Inc. on April 29, 2026.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Biogen Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Biogen Inc. (BIIB) $1,727,885 $23,646,004
2024 Biogen Inc. (BIIB) $1,600,000 $24,166,665
2023 Biogen Inc. (BIIB) $1,600,000 $4,069,913
2022 Biogen Inc. (BIIB) $153,846 $30,488,593

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.